$28.66
0.521.85%
At close: -
$28.66
0.000.00%
After Hours: 1:06 PM EDT
Immunocore Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Immunocore Hldgs using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $0.17 | $-0.34 | 150.0 % |
Jun 2024 | 2024-08-08 | $-0.23 | $-0.47 | 51.1 % |
Mar 2024 | 2024-05-08 | $-0.49 | $-0.36 | -36.1 % |
Dec 2023 | 2024-02-28 | $-0.40 | $-0.28 | -42.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $80.25M | $79.12M | 1.43 % |
Jun 2024 | 2024-08-08 | $75.40M | $74.72M | 0.91 % |
Mar 2024 | 2024-05-08 | $70.50M | $71.15M | -0.91 % |
Dec 2023 | 2024-02-28 | $70.16M | $67.23M | 4.36 % |
Immunocore Hldgs (IMCR) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $0.17, which beat the estimate of $-0.34.
The Actual Revenue was $80.2M, which beat the estimate of $79.1M.
Browse earnings estimates, EPS, and revenue on all stocks.